Addis Ababa University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Addis Ababa Ethiopia (1950)

Organization Overview

First Clinical Trial
2005
NCT00994695
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Addis Ababa University | Addis Abeba University | Aklilu Lemma Institute of Pathobiology, Addis Ababa University | Assistant Professor and Head, Center for Food Science and Nutrition, Addis Ababa Univeristy, Ethiopia | Center for Food Science and Nutrition, Addis Ababa University, Ethiopia | Center for Innovative Drug Development and Therapeutic Trials for Africa, Addis Ababa University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

HIV Infections (Phase 2)

HIV Seropositivity (Phase 3)

Hyperglycemia (Phase 1)

Leishmaniasis (Phase 3)

Leishmaniasis, Visceral (Phase 3)

Malaria (Phase 3)

Malaria, Vivax (Phase 3)

Meningitis (Phase 2)

Meningitis, Meningococcal (Phase 2)

Recurrence (Phase 3)

Schizophrenia (Phase 4)

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 14